Emerging treatment strategies for COVID-19 infection

por Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Korompoki, Eleni, Fotiou, Despina, Migkou, Magdalini, Tzanninis, Ioannis-Georgios, Psaltopoulou, Theodora, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios A.
Publicado 2020

Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit

por Liontos, Michalis, Kastritis, Efstathios, Markellos, Christos, Migkou, Magdalini, Eleftherakis-Papaiakovou, Evangelos, Koutsoukos, Konstantinos, Gavriatopoulou, Maria, Zagouri, Flora, Psaltopoulou, Theodora, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios
Publicado 2021

Treatment of Bing–Neel syndrome with first line sequential chemoimmunotherapy: A case report

por Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Moulopoulos, Lia-Angela, Manaios, Alexandros, Fotiou, Despina, Eleutherakis-Papaiakovou, Evangelos, Migkou, Magdalini, Bourgioti, Charis, Terpos, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios-Athanasios
Publicado 2019

Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study

por Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos
Publicado 2023

Prevalence of MGCS Among Patients With Monoclonal Gammopathies

por Theodorakakou, Foteini, Fotiou, Despina, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Spiliopoulou, Vassiliki, Malandrakis, Panagiotis, Migkou, Magdalini, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Terpos, Evangelos, Dimopoulos, Meletios A., Kastritis, Efstathios
Publicado 2023

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma

por Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Spiliopoulou, Vassiliki, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios, Gavriatopoulou, Maria
Publicado 2023

PB2127: REAL-WORLD EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN TRIPLE CLASS REFRACTORY PATIENTS WITH MULTIPLE MYELOMA

por Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Theodorakakou, Foteini, Spiliopoulou, Vassiliki, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios A., Gavriatopoulou, Maria
Publicado 2023

P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DAR...

por Terpos, Evangelos, Gavriatopoulou, Maria, Katodritou, Eirini, Hatjiharissi, Evdoxia, Dialoupi, Ioanna, Verrou, Evgenia, Manousou, Kyriaki, Gkolfinopoulos, Stavros, Migkou, Magdalini, Delimpasi, Sosana, Symeonidis, Argiris, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study

por Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos
Publicado 2022

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy

por Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Briasoulis, Alexandros, Gumeni, Sentiljana, Malandrakis, Panagiotis, Papanagnou, Eleni-Dimitra, Migkou, Magdalini, Kanellias, Nikolaos, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios A.
Publicado 2022

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome

por Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Fotiou, Despina, Migkou, Magdalini, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Roussou, Maria, Dialoupi, Ioanna, Malandrakis, Panagiotis, Theodorakakou, Foteini, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios
Publicado 2020

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine

por Gavriatopoulou, Maria, Terpos, Evangelos, Kastritis, Efstathios, Briasoulis, Alexandros, Gumeni, Sentiljana, Ntanasis-Stathopoulos, Ioannis, Sklirou, Aimilia D., Malandrakis, Panagiotis, Eleutherakis-Papaiakovou, Evangelos, Migkou, Magdalini, Trougakos, Ioannis P., Dimopoulos, Meletios A.
Publicado 2021

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

por Kastritis, Efstathios, Terpos, Evangelos, Roussou, Maria, Gavriatopoulou, Maria, Migkou, Magdalini, Eleutherakis-Papaiakovou, Evangelos, Fotiou, Despoina, Ziogas, Dimitrios, Panagiotidis, Ioannis, Kafantari, Eftychia, Giannouli, Stavroula, Zomas, Athanasios, Konstantopoulos, Konstantinos, Dimopoulos, Meletios A.
Publicado 2017

P826: THE CIRCULAR RNA OF THE CHAPERONIN-CONTAINING TCP1 SUBUNIT 3 GENE (CIRC-CCT3) IS OVEREXPRESSED IN MULTIPLE MYELOMA AND PREDICTS A FAVORABLE PROGNOSTIC OUTCOME, INDEPENDENTLY...

por Papatsirou, Maria, Kontos, Christos, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Theodorakakou, Foteini, Liacos, Christine, Mavrianou-Koutsoukou, Nefeli, Fotiou, Despina, Migkou, Magdalini, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios A., Scorilas, Andreas, Terpos, Evangelos
Publicado 2023

P884: BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: UPDATED RESULTS FROM THE PHASE 1/2 BELARD ST...

por Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Syrigou, Rodanthi, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Manousou, Kyriaki, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P928: OCULAR ADVERSE EVENTS AND FUNCTIONAL IMPACT IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHAS...

por Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Syrigou, Rodanthi, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Manousou, Kyriaki, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P861: PERSISTENT BONE MARROW AND IMAGING MRD NEGATIVITY AS CRITERIA TO STOP LENALIDOMIDE MAINTENANCE FOLLOWING ASCT: PRELIMINARY RESULTS OF A SINGLE-CENTER PROSPECTIVE COHORT STUDY

por Malandrakis, Panagiotis, Ntanasis-Stathopoulos, Ioannis, Kostopoulos, Ioannis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Spiliopoulou, Vassiliki, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Tsitsiloni, Ourania, Dimopoulos, Meletios A., Terpos, Evangelos
Publicado 2023

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era

por Ntanasis-Stathopoulos, Ioannis, Filippatos, Charalampos, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Eleutherakis-Papaiakovou, Evangelos, Spiliopoulou, Vassiliki, Syrigou, Rodanthi-Eleni, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios Athanasios, Terpos, Evangelos
Publicado 2023

Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in t...

por Gavriatopoulou, Maria, Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Eleutherakis-Papaiakovou, Evangelos, Papatheodorou, Athanasios, Kanellias, Nikolaos, Migkou, Magdalini, Fotiou, Despina, Dialoupi, Ioanna, Roussou, Maria, Kokkali, Nikoletta-Aikaterini, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2020

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study

por Gavriatopoulou, Maria, Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Briasoulis, Alexandros, Gumeni, Sentiljana, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios A.
Publicado 2021